Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-02-20 @ 12:35 PM
Study NCT ID:
NCT04836195
Status:
COMPLETED
Last Update Posted:
2025-04-17
First Post:
2021-03-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma
Sponsor:
Pacylex Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PCLX-001-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None